Paper41545643
Identification of hub genes and construction of a survival prediction model for patients with nasopharyngeal carcinoma.
Zhu J and 4 others. Sci Rep, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Identification of hub genes and construction of a survival prediction model for patients with nasopharyngeal carcinoma. Papers, record 41545643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41545643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identification of hub genes and construction of a survival prediction model for patients with nasopharyngeal carcinoma.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nasopharyngeal Carcinoma | Major topic |
| Nasopharyngeal Neoplasms | Major topic |
| Biomarkers, Tumor | Major topic |
| Humans | |
| Aurora Kinase A | |
| CDC2 Protein Kinase | |
| Prognosis | |
| Gene Expression Regulation, Neoplastic | |
| Protein Serine-Threonine Kinases | |
| Female | |
| Male | |
| Gene Expression Profiling | |
| Cell Cycle Proteins |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82501919 | National Natural Science Foundation of China | PubMed | ||
| 82370642 | National Natural Science Foundation of China | PubMed | ||
| 2025JJ60533 | Natural Science Foundation of Hunan Province | PubMed | ||
| 2024JJ5611 | Natural Science Foundation of Hunan Province | PubMed |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38704137 | Smoking-induced CCNA2 expression promotes lung adenocarcinoma tumorigenesis by boosting AT2/AT2-like cell differentiation. | Cancer Lett | 2024 | https://conductscience.org/library/papers/38704137 | PubMed |
| 2 | 29266238 | Rediscovery of NF-κB signaling in nasopharyngeal carcinoma: How genetic defects of NF-κB pathway interplay with EBV in driving oncogenesis? | J Cell Physiol | 2018 | https://conductscience.org/library/papers/29266238 | PubMed |
| 3 | 37056571 | Nasopharyngeal carcinoma ecology theory: cancer as multidimensional spatiotemporal "unity of ecology and evolution" pathological ecosystem. | Theranostics | 2023 | https://conductscience.org/library/papers/37056571 | PubMed |
| 4 | 32977361 | BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway. | Cancer Med | 2020 | https://conductscience.org/library/papers/32977361 | PubMed |
| 5 | 22995588 | A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. | Radiother Oncol | 2012 | https://conductscience.org/library/papers/22995588 | PubMed |
| 6 | 39962178 | Knockdown of CCNB2 inhibits the tumorigenesis of gastric cancer by regulation of the PI3K/Akt pathway. | Sci Rep | 2025 | https://conductscience.org/library/papers/39962178 | PubMed |
| 7 | 34908101 | CCNB2 is a novel prognostic factor and a potential therapeutic target in low-grade glioma. | Biosci Rep | 2022 | https://conductscience.org/library/papers/34908101 | PubMed |
| 8 | 33451333 | Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy. | Mol Cancer | 2021 | https://conductscience.org/library/papers/33451333 | PubMed |
| 9 | 26951679 | Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/26951679 | PubMed |
| 10 | 35490318 | Transcriptomic Signatures in Colorectal Cancer Progression. | Curr Mol Med | 2023 | https://conductscience.org/library/papers/35490318 | PubMed |
| 11 | 30207593 | Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2018 | https://conductscience.org/library/papers/30207593 | PubMed |
| 12 | 28687579 | Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era. | J Natl Compr Canc Netw | 2017 | https://conductscience.org/library/papers/28687579 | PubMed |
| 13 | 35014077 | The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients. | J Cell Biochem | 2022 | https://conductscience.org/library/papers/35014077 | PubMed |
| 14 | 25521941 | cytoHubba: identifying hub objects and sub-networks from complex interactome. | BMC Syst Biol | 2014 | https://conductscience.org/library/papers/25521941 | PubMed |
| 15 | 28031050 | Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy. | Chin J Cancer | 2016 | https://conductscience.org/library/papers/28031050 | PubMed |
| 16 | 31178151 | Nasopharyngeal carcinoma. | Lancet | 2019 | https://conductscience.org/library/papers/31178151 | PubMed |
| 17 | 39417505 | KEGG: biological systems database as a model of the real world. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/39417505 | PubMed |
| 18 | 36587494 | AURKA, as a potential prognostic biomarker, regulates autophagy and immune infiltration in nasopharyngeal carcinoma. | Immunobiology | 2023 | https://conductscience.org/library/papers/36587494 | PubMed |
| 19 | 12692836 | Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation. | J Pathol | 2003 | https://conductscience.org/library/papers/12692836 | PubMed |
| 20 | 31516577 | Bioinformatics analysis identifies hub genes and pathways in nasopharyngeal carcinoma. | Oncol Lett | 2019 | https://conductscience.org/library/papers/31516577 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42145838 | Co-Culture of nasopharyngeal carcinoma cells and fibroblasts induces altered integrin expression associated with 3D structural formation. | Cytotechnology | 2026 | https://conductscience.org/library/papers/42145838 |
Source PubMed
Genes27
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41545643
GET https://conductscience.org/api/papers/v1/41545643/references?page=2